semaglutide diabetes study united states A new from UC San Diego offers early clinical evidence that semaglutide, a widely used GLP-1 receptor agonist, may slow biological aging. In a randomized, placebo-controlled trial, researchers observed a 9% Weekly semaglutide improves blood sugar

The drug is also significantly cheaper in China compared to the U.S

Semaglutide 10mg is a prescription injectable medication belonging to the GLP-1 (glucagon-like peptide-1) receptor agonist class

Aerobic exercise at moderate intensity (5070% max heart rate) for 150 minutes weekly increases GLP-1 receptor expression in the hypothalamus and vagus nerve terminals

This decision should involve your provider and may depend on your personal/family history of weight cycling, metabolic comorbidities, and behavioral capacity

Higher protein intake (1.2-1.6g per kg ideal body weight) is critical because appetite suppression makes it easy to under-eat protein